Postpartum Glucose Follow-up Screening Among Women With Gestational Diabetes Mellitus: A Retrospective Cohort Study
10.1097/FM9.0000000000000252
- VernacularTitle:Postpartum Glucose Follow-up Screening Among Women With Gestational Diabetes Mellitus: A Retrospective Cohort Study
- Author:
Jiani ZHANG
1
;
Tingting XU
;
Qi CAO
;
Chihui MAO
;
Fan ZHOU
;
Xiaodong WANG
Author Information
1. Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus, gestational;
Follow-up;
Influencing factors;
Postpartum;
Screening
- From:
Maternal-Fetal Medicine
2024;06(4):236-242
- CountryChina
- Language:English
-
Abstract:
Objective::To evaluate the impact of pregestational and gestational characteristics on postpartum glucose follow-up screening (PGFS) compliance in women diagnosed with gestational diabetes mellitus (GDM) in southwest China.Methods::This retrospective cohort study was conducted in West China Second Hospital, Sichuan University. Pregestational and gestational factors were extracted from hospital records and compared between women who completed PGFS and those who did not. The screening method chosen was the 75 g oral glucose tolerance test (OGTT), performed 4–12 weeks postpartum. Univariate analysis, logistic regression analysis, and Cochran-Armitage test were used to assess associations between maternal characteristics and PGFS compliance.Results::A total of 3047 women with GDM were included, with a PGFS completion rate of 47.2%. Of those who completed PGFS, 430 women (29.9%) presented abnormal results: 1.8% with impaired fasting glucose (IFG), 24.1% with impaired glucose tolerance (IGT), 2.2% with both IFG and IGT, and 1.8% with suspected diabetes. Independent factors associated with non-compliance to PGFS included higher pregestational BMI (odds ratio ( OR): 0.952; 95% confidence interval ( CI): 0.922, 0.984), multipara ( OR: 0.721; 95% CI: 0.593, 0.877), use of assisted reproduction technology (ART) ( OR: 1.427; 95% CI: 1.080, 1.885), excessive gestational weight gain ( OR: 0.956; 95% CI: 0.936, 0.977), elevated fasting plasma glucose (FPG) prior to delivery ( OR: 0.909; 95% CI: 0.835, 0.988), and undergoing cesarean section ( OR: 1.232; 95% CI: 1.017, 1.492). PGFS completion rates significantly decreased with increasing pregestational BMI and earlier gestational age ( P < 0.001). Conclusion::Establishing dedicated postpartum follow-up teams and targeting women with higher pregestational BMI, multiparity, ART use, excessive gestational weight gain, elevated pre-delivery FPG, and those undergoing cesarean section are critical to improving postpartum GDM management.
